Morpholine dopamine agonists
US7576081B2 · kind B2 · utility
0Cited by
18References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2006 |
| Grant date | Aug 18, 2009 |
| Priority date | — |
| Expiry date | Jun 19, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides for compounds of formula (I), (Ia) and (Ib)Wherein:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.